Author Title Type [ Year(Asc)]
Filters: Author is Sotgia, Federica  [Clear All Filters]
Lamb, R., Ozsvari, B., Lisanti, C.L., Tanowitz, H.B., Howell, A., Martinez-Outschoorn, U.E., Sotgia, F., and Lisanti, M.P. (2015). Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease.Oncotarget.
Lamb, R., Fiorillo, M., Chadwick, A., Ozsvari, B., Reeves, K.J., Smith, D.L., Clarke, R.B., Howell, S.J., Cappello, A.Rita, Martinez-Outschoorn, U.E., et al. (2015). Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy.Oncotarget.
Farnie, G., Sotgia, F., and Lisanti, M.P. (2015). High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.Oncotarget.
De Luca, A., Fiorillo, M., Peiris-Pagès, M., Ozsvari, B., Smith, D.L., Sánchez-Alvarez, R., Martinez-Outschoorn, U.E., Cappello, A.Rita, Pezzi, V., Lisanti, M.P., et al. (2015). Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.Oncotarget.
Lamb, R., Bonuccelli, G., Ozsvari, B., Peiris-Pagès, M., Fiorillo, M., Smith, D.L., Bevilacqua, G., Mazzanti, C.Maria, McDonnell, L.A., Naccarato, A.Giuseppe, et al. (2015). Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.Oncotarget.
Lamb, R., Harrison, H., Smith, D.L., Townsend, P.A., Jackson, T., Ozsvari, B., Martinez-Outschoorn, U.E., Pestell, R.G., Howell, A., Lisanti, M.P., et al. (2015). Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction.Oncotarget.